Comparison of the EUCAST and CLSI Broth Microdilution Methods for Testing Isavuconazole, Posaconazole, and Amphotericin B against Molecularly Identified Mucorales Species

被引:43
作者
Chowdhary, Anuradha [1 ]
Singh, Pradeep Kumar [1 ]
Kathuria, Shallu [1 ]
Hagen, Ferry [2 ]
Meis, Jacques F. [2 ,3 ]
机构
[1] Univ Delhi, Vallabhbhai Patel Chest Inst, Dept Med Mycol, Delhi 110007, India
[2] Canisius Wilhelmina Hosp, Dept Med Microbiol & Infect Dis, Nijmegen, Netherlands
[3] Radboudumc, Dept Med Microbiol, Nijmegen, Netherlands
关键词
ANTIFUNGAL SUSCEPTIBILITY; MUCORMYCOSIS; MANAGEMENT; DIAGNOSIS; BEDSIDE; BENCH;
D O I
10.1128/AAC.02107-15
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
We compared EUCAST and CLSI antifungal susceptibility testing (AFST) methods for triazoles and amphotericin B against 124 clinical Mucorales isolates. The EUCAST method yielded MIC values 1- to 3-fold dilutions higher than those of the CLSI method for amphotericin B. The essential agreements between the two methods for triazoles were high, i.e., 99.1% (voriconazole), 98.3% (isavuconazole), and 87% (posaconazole), whereas it was significantly lower for amphotericin B (66.1%). Strategies for harmonization of the two methods for Mucorales AFST are warranted.
引用
收藏
页码:7882 / 7887
页数:6
相关论文
共 24 条
[1]   Activity of Posaconazole and Other Antifungal Agents against Mucorales Strains Identified by Sequencing of Internal Transcribed Spacers [J].
Alastruey-Izquierdo, Ana ;
Victoria Castelli, Maria ;
Cuesta, Isabel ;
Monzon, Araceli ;
Cuenca-Estrella, Manuel ;
Luis Rodriguez-Tudela, Juan .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2009, 53 (04) :1686-1689
[2]  
[Anonymous], 1990, PCR protocols: a guide to methods and applications, DOI DOI 10.1016/B978-0-12-372180-8.50042-1
[3]  
Arendrup M. C., 2014, METHOD DETERMINATION
[4]  
Chowdhary A, 2015, 55 INT C ANT AG CHEM
[5]   Molecular characterization and in vitro antifungal susceptibility of 80 clinical isolates of mucormycetes in Delhi, India [J].
Chowdhary, Anuradha ;
Kathuria, Shallu ;
Singh, Pradeep Kumar ;
Sharma, Brijesh ;
Dolatabadi, Somayeh ;
Hagen, Ferry ;
Meis, Jacques F. .
MYCOSES, 2014, 57 :97-107
[6]  
Clinical and Laboratory Standards Institute, 2008, M38A2 CLSI
[7]   ESCMID† and ECMM‡ joint clinical guidelines for the diagnosis and management of mucormycosis 2013 [J].
Cornely, O. A. ;
Arikan-Akdagli, S. ;
Dannaoui, E. ;
Groll, A. H. ;
Lagrou, K. ;
Chakrabarti, A. ;
Lanternier, F. ;
Pagano, L. ;
Skiada, A. ;
Akova, M. ;
Arendrup, M. C. ;
Boekhout, T. ;
Chowdhary, A. ;
Cuenca-Estrella, M. ;
Freiberger, T. ;
Guinea, J. ;
Guarro, J. ;
de Hoog, S. ;
Hope, W. ;
Johnson, E. ;
Kathuria, S. ;
Lackner, M. ;
Lass-Floerl, C. ;
Lortholary, O. ;
Meis, J. F. ;
Meletiadis, J. ;
Munoz, P. ;
Richardson, M. ;
Roilides, E. ;
Tortorano, A. M. ;
Ullmann, A. J. ;
van Diepeningen, A. ;
Verweij, P. ;
Petrikkos, G. .
CLINICAL MICROBIOLOGY AND INFECTION, 2014, 20 :5-26
[8]   Healthcare-associated outbreaks due to Mucorales and other uncommon fungi [J].
Davoudi, Setareh ;
Graviss, Linda S. ;
Kontoyiannis, Dimitrios P. .
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2015, 45 (07) :767-773
[9]   Successful isavuconazole salvage therapy in a patient with invasive mucormycosis [J].
Ervens, J. ;
Ghannoum, M. ;
Graf, B. ;
Schwartz, S. .
INFECTION, 2014, 42 (02) :429-432
[10]   Multicenter Evaluation of MIC Distributions for Epidemiologic Cutoff Value Definition To Detect Amphotericin B, Posaconazole, and Itraconazole Resistance among the Most Clinically Relevant Species of Mucorales [J].
Espinel-Ingroff, A. ;
Chakrabarti, A. ;
Chowdhary, A. ;
Cordoba, S. ;
Dannaoui, E. ;
Dufresne, P. ;
Fothergill, A. ;
Ghannoum, M. ;
Gonzalez, G. M. ;
Guarro, J. ;
Kidd, S. ;
Lass-Floerl, C. ;
Meis, J. F. ;
Pelaez, T. ;
Tortorano, A. M. ;
Turnidge, J. .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2015, 59 (03) :1750-1755